Analyzing Ratios: Iterum Therapeutics Plc (ITRM)’s Financial Story Unveiled

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Iterum Therapeutics Plc (NASDAQ: ITRM) closed at $1.37 in the last session, up 0.74% from day before closing price of $1.36. In other words, the price has increased by $0.74 from its previous closing price. On the day, 0.59 million shares were traded. ITRM stock price reached its highest trading level at $1.42 during the session, while it also had its lowest trading level at $1.31.

Ratios:

We take a closer look at ITRM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.85 and its Current Ratio is at 0.85.

On March 15, 2021, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $2.50.

RBC Capital Mkts Downgraded its Outperform to Sector Perform on June 02, 2020, whereas the target price for the stock was revised from $7 to $2.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 22 ’23 when Dunne Michael W. bought 25,000 shares for $1.40 per share. The transaction valued at 35,000 led to the insider holds 113,754 shares of the business.

Dunne Michael W. bought 10,000 shares of ITRM for $18,442 on Dec 18 ’23. The Director now owns 88,754 shares after completing the transaction at $1.84 per share. On Nov 22 ’23, another insider, Dunne Michael W., who serves as the Director of the company, bought 20,000 shares for $2.03 each. As a result, the insider paid 40,690 and bolstered with 78,754 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ITRM now has a Market Capitalization of 31107220 and an Enterprise Value of 40783152.

Stock Price History:

Over the past 52 weeks, ITRM has reached a high of $2.50, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is 18.56%, while the 200-Day Moving Average is calculated to be 2.92%.

Shares Statistics:

According to the various share statistics, ITRM traded on average about 2.41M shares per day over the past 3-months and 1067830 shares per day over the past 10 days. A total of 22.71M shares are outstanding, with a floating share count of 21.95M. Insiders hold about 3.33% of the company’s shares, while institutions hold 7.47% stake in the company. Shares short for ITRM as of 1730332800 were 2531938 with a Short Ratio of 1.05, compared to 1727654400 on 215246. Therefore, it implies a Short% of Shares Outstanding of 2531938 and a Short% of Float of 11.53.

Most Popular